Health
NYSE Content Advisory: Pre-Market Update + Fed cuts interest rates by 0.25%
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Fed cuts interest ra...
2025-09-18 20:55
3805
Beyond Ventures Champions HKIC's new initiatives outlined in The Policy Address 2025
Strategic partnership with the HKIC fuels growth across biotech, hardcore and greentech sectors, reinforcingHong Kong's role as a super-connector and super value-adder in the global innovation landscape HONG KONG, Sept. 18, 2025 /PRNewswire/ -- Hong Kong-based venture capital firm Beyond Venture...
2025-09-18 17:57
2010
Grace Lu rejoining Russell Reynolds Associates Singapore as Managing Director for Healthcare Practice
SINGAPORE, Sept. 18, 2025 /PRNewswire/ -- Russell Reynolds Associates
2025-09-18 14:34
1707
Investing in Futures: Education Cannot Wait Reaches 14 Million Children in Crises Worldwide
New ECW Results Report highlights transformative education outcomes for
children and adolescents in emergencies and protracted crises and calls for
urgent funding to sustain progress.
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Education Cannot Wait (ECW
2025-09-18 12:00
1950
Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...
2025-09-18 12:00
1735
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings...
2025-09-18 10:28
1734
/C O R R E C T I O N -- CAIR/
In the news release, "EchoCare" Ultrasound Large Model Launched in Hong Kong as CAIR Showcases Large-Scale Ultrasound Dataset Training Achievements, issued 17-Sep-2025 by CAIR over PR Newswire, we are advised by the company that the headline, 2nd paragraph, 6th paragraph, and 7th paragraph have be...
2025-09-18 10:22
2718
Sunway Medical Centre named Top Malaysian Smart Hospital in Newsweek's World's Best Smart Hospitals 2026 ranking
SUNWAY CITY, Malaysia, Sept. 18, 2025 /PRNewswire/ -- Sunway Medical Centre,
Sunway City (SMC) has been honoured as top Malaysian hospital and debuted in
the top 350 hospitals in the world, as per the latest Newsweek's World's Best
Smart Hospitals 2026 ranking.
2025-09-18 09:00
2633
Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
YANTAI, China, Sept. 18, 2025 /PRNewswire/ -- RemeGen (688331.SH/09995.HK) announced that the 48-week open-label extension (OLE) data from China Phase III clinical study of telitacicept (RC18, brand name: 泰爱®, a BLyS/APRIL dual-target fusion protein innovative drug independently developed by Reme...
2025-09-18 09:00
1772
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code...
2025-09-18 08:15
2008
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs)...
2025-09-18 07:30
1686
MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.
* First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. * Data shows low dose of HN2301 reprogrammed up to 60% of CD8+ CAR+ T-cells in the peripheral blood of patients, resulting in complete depletion of cir...
2025-09-18 05:09
1454
Terra Oleo Emerges from Stealth with US$3.1M in Funding and Breakthrough Energy Fellow Selection to Reinvent Fats and Oils
SINGAPORE, Sept. 18, 2025 /PRNewswire/ -- Terra Oleo, a Singapore-based biotechnology company, today announced its emergence from stealth withUS$3.1 million in funding from a group of investors, and support from Breakthrough Energy's prestigious Fellows Program. As part of this highly selective g...
2025-09-18 00:00
3261
Dornier MedTech America launches Hoover™ and AXIS® II SLIM, raising the bar in kidney stone treatment
KENNESAW, Ga., Sept. 17, 2025 /PRNewswire/ -- Dornier MedTech America (DMTA)
has announced the full U.S. commercial launch of its Dornier Hoover Flexible
and Navigable Suction Ureteral Access Sheath (FANS) and Dornier Axis II Slim
single-use ureteroscope with a 5.6Fr. distal tip.
2025-09-17 22:00
1583
NYSE Content Advisory: Pre-Market Update + Fed decision & StubHub celebrates IPO
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Fed decision & StubH...
2025-09-17 20:55
4176
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral dose Additional findings include dose-dependent reductions in PMS1 mRNA, excellent brain penetration, and a favorable safety profile SKY-0515's Phase 2/3 FALCON-HD t...
2025-09-17 20:44
1433
Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders
SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop2MW7141, a novel dual-target siRNA cand...
2025-09-17 20:00
1473
Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
* EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through its partner Qilu Pharmaceutical. DAEJEON, South Korea, Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has ...
2025-09-17 15:40
1957
Sun Life and Beyond Sport's "Hoops + Health" program empowers more than 48,000 young people across Asia to get active
Building on last year's success, the program scaled up in its second year to inspire healthier lifestyles through basketball, with a 250% surge in participation HONG KONG, Sept. 17, 2025 /PRNewswire/ -- Sun Life, in partnership with global sport for social change foundation Beyond Sport, has suc...
2025-09-17 14:28
2087
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
* Maintained Quarterly Operational Profitability * Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY * Maintained Positive Operating Cash Flow in the First Half of the Year SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a l...
2025-09-17 14:00
4320
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
Asia Pacific Defies Global Headwinds: Mastercard Economics Institute 2026 Outlook
[Picked up by 277 media titles]
2025-12-10 09:00